Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove


Nanoscopic Imaging of Human Tissue Sections via Physical and Isotropic Expansion

doi: 10.3791/60195 Published: September 25, 2019


Nanoscale imaging of clinical tissue samples can improve understanding of disease pathogenesis. Expansion pathology (ExPath) is a version of expansion microscopy (ExM), modified for compatibility with standard clinical tissue samples, to explore the nanoscale configuration of biomolecules using conventional diffraction limited microscopes.


In modern pathology, optical microscopy plays an important role in disease diagnosis by revealing microscopic structures of clinical specimens. However, the fundamental physical diffraction limit prevents interrogation of nanoscale anatomy and subtle pathological changes when using conventional optical imaging approaches. Here, we describe a simple and inexpensive protocol, called expansion pathology (ExPath), for nanoscale optical imaging of common types of clinical primary tissue specimens, including both fixed-frozen or formalin-fixed paraffin embedded (FFPE) tissue sections. This method circumvents the optical diffraction limit by chemically transforming the tissue samples into tissue-hydrogel hybrid and physically expanding them isotropically across multiple scales in pure water. Due to expansion, previously unresolvable molecules are separated and thus can be observed using a conventional optical microscope.


or Start trial to access full content. Learn more about your institution’s access to JoVE content here

Investigating the molecular organization of tissues in a three-dimensional (3D) context can provide new understanding of biological functions and disease development. However, these nanoscale environments are beyond the resolution capabilities of conventional diffraction limited microscopes (200−300 nm), where the minimal resolvable distance, d is defined by d α λ/NA. Here λ is the wavelength of light and NA is the numerical aperture (NA) of the imaging system. Recently, direct visualization of fluorescently labeled molecules has been made possible by newly developed super-resolution imaging techniques1,2,3, including stimulated emission depletion (STED), photo-activated localization microscopy (PALM), stochastic optical reconstruction microscopy (STORM), and structured illumination microscopy (SIM). Although these imaging techniques have revolutionized understanding of biological function at the nanoscale, in practice, they often rely on expensive and/or specialized equipment and image processing steps, can have slower acquisition time comparing to conventional optical imaging, require fluorophores with specific characteristics (such as photo-switching capability and/or high photostability). In addition, it remains a challenge to perform 3D super-resolution imaging on tissue specimens.

Expansion microscopy (ExM), first introduced in 20154, provides an alternative means of imaging nanoscale features (<70 nm) by physically expanding preserved samples embedded in a swellable polyelectrolyte hydrogel. Here, key biomolecules and/or labels are anchored in situ to a polymer network that can be isotopically expanded after chemical processing. Because the physical expansion increases the total effective resolution, molecules of interest can then be resolved using conventional diffraction-limited imaging systems. Since the publication of the original protocol, where custom synthesized fluorescent labels were anchored to the polymer network4, new strategies have been used to directly anchor proteins (protein retention ExM, or proExM)5,6,7,8,9 and RNA9,10,11,12 to the hydrogel, and increase physical magnification through iterative expansion13 or adapting gel chemistry8,14,15.

Here we present an adapted version of proExM, called expansion pathology (ExPath)16, which has been optimized for clinical pathology formats. The protocol converts clinical samples, including formalin-fixed paraffin-embedded (FFPE), hematoxylin and eosin (H&E) stained, and fresh-frozen human tissue specimens mounted on glass slides, into a state compatible with ExM. Proteins are then anchored to the hydrogel and mechanical homogenization is performed (Figure 1)16. With a 4-fold linear expansion of the samples, multicolor super-resolution (~70 nm) images can be obtained using a conventional confocal microscope having only a ~300 nm resolution and can also be combined with other super-resolution imaging techniques.

Subscription Required. Please recommend JoVE to your librarian.


or Start trial to access full content. Learn more about your institution’s access to JoVE content here

1. Preparation of Stock Reagents and Solutions

  1. Prepare gelling solution components.
    Solution concentrations are given in g/mL (w/v percent).
    1. Make the following stock solutions: 38% (w/v) sodium acrylate (SA), 50% (w/v) acrylamide (AA), 2% (w/v) N,N′-methylenebisacrylamide (Bis), and 29.2% (w/v) sodium chloride (NaCl). Dissolve the compounds in doubly deionized water (ddH2O). Use the amounts in Table 1 as a reference; prepared solutions can be scaled up or down in volume as needed. For example, to make 10 mL of a 38% (w/v) SA solution, add 1.9 g SA to a graduated 10 mL cylinder and add ddH2O to a volume of 5 mL.
    2. Prepare 9.4 mL of monomer solution at a 1.06x concentration as shown in Table 1.
      NOTE: This will result in a 1x concentration after addition of the initiator, accelerator, and inhibitor. The monomer stock can be stored at 4 °C for up to 3 months, or at -20 °C for long-term storage.
    3. Prepare the following stock solutions separately in ddH2O: 0.5% (w/v) of the inhibitor 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (4HT), which inhibits gelation to enable diffusion of the gelling solution into tissues, 10% (v/v) of the initiator tetramethylethylenediamine (TEMED), which accelerates radical generation by ammonium persulfate (APS), and 10% (w/v) APS which initiates the gelling process.
      NOTE: Stock solutions of 4HT and TEMED can be prepared in 1 mL aliquots and stored at -20 °C for at least 6 months. APS has been found to lose efficacy after long-term storage and is best prepared in small quantities (<0.1 mL) immediately before gelling.
  2. Prepare digestion buffer (50 mM Tris pH 8.0, 25 mM EDTA, 0.5% [w/v] nonionic surfactant, 0.8 M NaCl) by combining 25 mL of 1 M Tris pH 8 (3.03 g of Tris base in 25 mL of ddH2O), 25 mL of EDTA (0.5 M pH 8), 2.25 g of nonionic surfactant, and 23.38 g of NaCl. Add ddH2O for a total volume of 500 mL.
    NOTE: The solution can be scaled up or down as needed and be stored in at 4 °C. Proteinase K (ProK) will be added immediately before the digestion step.
  3. Prepare 20 mM sodium citrate solution by combining 2.941 g of sodium citrate tribasic dihydrate with 500 mL of ddH2O and adjusting pH to 8.0 at room temperature (RT). Scale the volume of stock as needed.
  4. Prepare a stock solution of 6-((acryloyl)amino)hexanoic acid, succinimidyl ester (acryloyl-X, SE; AcX), the anchoring compound. Dissolve AcX in 500 µL of anhydrous dimethyl sulfoxide (DMSO) for a final concentration of 10 mg/mL.
    NOTE: The solution can be stored in a desiccated environment at -20 °C in 20 µL aliquots.
  5. If not using commercially available buffers for immunostaining, prepare blocking buffer. Use a blocking buffer of 5% (v/v) normal animal serum and 0.1% (w/v) nonionic surfactant in 1x phosphate-buffered saline (PBS) and select the serum based on the host animal of the secondary antibodies. For example, to prepare 500 mL blocking buffer for antibodies raised in goat, combine 25 mL of goat serum, 0.45 g of nonionic surfactant, and 1x PBS to a volume of 500 mL.

2. Preparation of Archived and Freshly Prepared Clinical Tissue Slides for ExPath

  1. Convert the tissue into an ExPath compatible format. Choose one of the four following steps (2.1.1−2.1.4) based on how the specimen was prepared: FFPE slides, stained FFPE slides, or unfixed or fixed frozen tissue slides in optimum cutting temperature (OCT) solution.
    These are based on standard recovery steps for pathology samples and are not specific to the ExPath protocol.
    1. FFPE clinical samples
      1. Prepare 30 mL of 95% ethanol, 70% ethanol, and 50% ethanol. Measure out 30 mL of xylene, 100% ethanol, and ddH2O.
      2. Place the slide with the sample in a 50 mL conical using forceps and add 15 mL of xylene. Cap the tube and place it horizontally on an orbital shaker at approximately 60 rpm and incubate at RT for 3 min for each solution. Repeat with the remaining 15 mL xylene.
      3. Repeat step with 100% ethanol, 95% ethanol, 70% ethanol, 50% ethanol, and ddH2O in place of xylene.
    2. Stained and mounted permanent slides
      1. Place the slide in a 100 mm Petri dish and cover with xylene. Carefully remove the coverslip using a razor blade. If the coverslip is not easily removed, return the slide to the xylene until the coverslip loosens.
      2. Process using the steps for FFPE samples (steps−
        NOTE: In the case of H&E stained slides, the stains are eliminated during the expansion process.
    3. Unfixed frozen tissue slides in OCT solution
      1. Fix the tissue in acetone at -20 °C for 10 min.
      2. Wash the samples with 1x PBS solution 3 times for 10 min each at RT.
    4. Previously fixed, frozen clinical tissue slides
      1. Incubate the slides for 2 min at RT to melt the OCT solution.
      2. Wash the sample with 1x PBS solution 3 times for 5 min each at RT.
  2. Perform heat treatment for antigen retrieval on all samples after format conversion.
    1. Add 20 mM citrate solution (pH 8 at RT) in a heat resistant container, such as a slide staining jar.
      NOTE: There should be enough solution to cover the tissue mounted on the slide (50 mL for a standard slide staining jar).
    2. Heat the citrate solution to 100 °C in the microwave and place the slide in the solution. Immediately transfer the container to an incubation chamber and incubate at 60 °C for 30 min.
      NOTE: The protocol can be paused here. Slides can be placed in Petri dishes and covered in 1x PBS and stored at 4 °C.
  3. Stain the sample using standard immunofluorescence (IF)/immunohistochemistry (IHC) staining protocols.
    Specific primary and secondary antibody concentrations and staining durations are dependent on the concentrations suggested by the manufacturer or by optimization for the specific experiment.
    1. Use a hydrophobic pen to draw a boundary around the tissue section(s) on the slide to minimize the volume of solution needed to cover the tissue. Place the slide in a dish large enough to fit the slide. For a standard 3-inch slide, use a 100 mm Petri dish.
      NOTE: The hydrophobic pen does not interfere with the polymerization of the sample nor the digestion process.
    2. Incubate the tissue with blocking buffer for 1 h at 37 °C, 2 h at RT, or 4 °C overnight to reduce nonspecific binding.
    3. Dilute primary antibodies to the desired concentration in the appropriate amount of prepared blocking buffer (or other preferred staining buffer). Incubate the tissues with the primary antibody solution for at least 3 h at RT or 37 °C, or overnight at 4 °C.
      NOTE: Samples should be placed in a humidified container (such as a Petri dish with a damp wipe) to prevent the tissue from drying out. Typically, antibodies have been diluted to 1:100−1:500 in 200−500 µL of buffer, depending on the tissue size and antibody used.
    4. Wash the tissue with prepared blocking buffer (or other preferred washing buffer) 3 times for 10 min at RT.
    5. Dilute secondary antibodies (and 300 nM 4′,6-diamidino-2-phenylindole [DAPI] if desired), in prepared blocking buffer (or other preferred staining buffer) to a concentration of approximately 10 µg/mL. Incubate the tissue in the secondary antibody solution for at least 1 h at RT or 37 °C.
      NOTE: Timing may be adjusted depending on the antibodies used and the thickness of the tissue. Secondary antibodies containing cyanine dyes (Cy3, Cy5, Alexa 647) are not compatible with the ExM protocol when applied pre-polymerization. Suggested dyes include Alexa 488 (green), Alexa 546 (orange/red), and Atto 647N or CF633 (far-red). DAPI must be reapplied after expansion, as it is washed away during the expansion process.
    6. Wash the tissue with prepared blocking buffer (or other preferred washing buffer) 3 times for 10 min each at RT.
      NOTE: The protocol can be paused here. Slides can be placed in Petri dishes and covered in 1x PBS and stored at 4 °C.
    7. Perform fluorescent imaging using a conventional wide-field microscope, confocal microscope, or other imaging system of choice.
      NOTE: This step is required to determine biological length using the expansion factor by comparing pre- and post-expansion images. To facilitate post-expansion imaging, easily identifiable regions of interest should be selected and images at both low and high magnification should be collected.

3. In Situ Polymerization of Specimens

  1. Incubate the specimen in anchoring solution.
    1. Prepare the anchoring solution (typically 250 µL is enough to cover the tissue section) by diluting the AcX stock solution in 1x PBS to a concentration of 0.03 mg/mL for samples fixed with non-aldehyde fixatives or 0.1 mg/mL for samples fixed with aldehyde fixatives, which have fewer free amines available to react with AcX.
    2. Place the slide in a 100 mm Petri dish and pipette the anchoring solution over the tissue. Incubate for at least 3 h at RT or overnight at 4 °C.
  2. Incubate the samples in gelling solution.
    1. Prepare at least 100-fold excess volume of gelling solution. Per 200 µL, combine the following, in order: 188 µL of monomer solution, 4 µL of 0.5% 4HT stock solution (1:50 dilution, final concentration: 0.01%), 4 µL of 10% TEMED stock solution (1:50 dilution, final concentration 0.2%), and 4 µL of 10% APS stock solution (1:50 dilution, final concentration 0.2%).
      NOTE: Gelling solution should be made immediately before use. The solution should be kept at 4 °C and the APS solution should be added last, to prevent premature gelling.
    2. Remove excess solution from the tissue section and place the slide in a 100 mm Petri dish. Add fresh, cold gelling solution to the sample and incubate the mixture on the tissue for 30 min at 4 °C, to allow diffusion of solution into the tissue.
  3. Construct a chamber on the slide around the sample (Figure 2A) without disturbing the gelling solution.
    1. Make spacers for the gelling chamber by thinly cutting pieces of cover glass using a diamond knife.
      NOTE: To facilitate imaging post expansion, the spacers should be close in thickness to the tissue specimen to reduce the amount of blank gel above the tissue. Number 1.5 glass can be used for standard clinical samples (5−10 µm). Cover glass pieces can be stacked for thicker samples.
    2. Secure the spacers on either side of the tissue using droplets of water (~10 µL).
    3. Carefully place a cover glass lid over the slide, making sure to avoid trapping air bubbles over the tissue (Figure 2B).
  4. Incubate the sample at 37 °C in a humidified environment (such as a closed Petri dish with a damp wipe) for 2 h.
    NOTE: The protocol can be paused here. The slide chamber can be stored inside a sealed Petri dish at 4 °C.

4. Sample Digestion

  1. Remove the lid of the gelling chamber by gently sliding a razor blade under the coverslip and slowly lifting the coverslip off the gel surface. Trim the blank gel around the tissue to minimize volume. Cut the gel asymmetrically to track the orientation of the gel after homogenization, since the sample will become transparent.
    1. Dilute ProK by 1:200 in digestion buffer (final concentration 4 U/mL) before use. Prepare enough solution to completely submerge the gel; a single well of a four-well plastic cell culture plate requires at least 3 mL per well.
    2. Incubate the sample in a closed container containing the digestion buffer for 3 h at 60 °C. If the sample does not detach from the slide during digestion, use a razor blade to gently remove the sample.
      NOTE: The specimen should be completely submerged in digestion buffer to prevent the sample from drying out and placed in a covered container (small slide box, plastic well, Petri dish, etc.) that can be sealed with film.

5. Sample Expansion and Imaging

  1. Use a soft paint brush to transfer the specimen into 1x PBS in a container compatible with the desired imaging system and large enough to accommodate the fully expanded gel. Make sure that the tissue is placed with the sample-side down if imaging on an inverted system or up if imaging on an upright system to minimize the distance from the imaging objective to the sample. Flip the gel using a soft paint brush if needed.
    NOTE: Side-illumination from an LED can be used to make them visible in liquid. A standard 6-well plate can accommodate samples that have a pre-expanded diameter less than 0.6 cm. A glass bottom well plate should be used for imaging on an inverted system.
  2. Wash the samples in 1x PBS at RT for 10 min. If desired, re-stain the sample with 300 nM DAPI as the digestion process washes away the DAPI stain. Remove PBS and stain with 300 nM DAPI diluted in 1x PBS for 20 min at RT, followed by a 10 min wash with 1x PBS at RT.
    NOTE: The samples can be covered with 1x PBS and stored at 4 °C before proceeding to the next step.
  3. To expand the samples, replace the PBS and wash with an excess volume of ddH2O (at least 10x the final gel volume) 3−5 times for 10 min each, at RT.
    NOTE: After the 3rd or 4th wash, the specimen’s expansion should begin to plateau. For storage, to prevent bacterial growth, the ddH2O can be supplemented with 0.002%−0.01% sodium azide (NaN3). In this case, the final expansion factor is reversibly reduced by 10%.
  4. Perform fluorescence imaging using a conventional wide-field microscope, confocal microscope, or other imaging system of choice.
    NOTE: To prevent gels from drifting, excess liquid can be removed from the well. Gels can also be immobilized with 1.5−2% low-melt agarose. Prepare 1.5−2%(w/v) low-melt agarose in water in a container 2−4 times the volume of solution. Warm the solution in a 40 °C water bath or in a microwave for 10−20 s to melt the solution. Pipette the melted agarose around the edges of the gel. After allowing the agarose to harden at RT or 4 °C, add water to the sample to prevent dehydration.

Subscription Required. Please recommend JoVE to your librarian.

Representative Results

or Start trial to access full content. Learn more about your institution’s access to JoVE content here

If the protocol has been successfully carried out (Figure 1), samples will appear as a flat and transparent gel after mechanical homogenization (Figure 3A) and can expand by a factor of 3−4.5x in water (Figure 3B), providing an effective resolution of ~70 nm depending on the final expansion factor and imaging system used5,16. Figure 4 shows example images of a 5 µm thick FFPE kidney sample processed using the ExPath protocol. Full expansion of the gelled samples resulted in a 4.5x expansion factor in water, giving an effective resolution of ~63 nm when imaged using a 0.95 NA objective. The tissue was first pre-processed with xylene to remove paraffin and rehydrated (section 2.1.1), followed by antigen-retrieval with the citrate buffer (section 2.2). The recovered tissue was then stained with antibodies for alpha-actinin 4 (ACTN4) and vimentin, along with DAPI to visualize nuclear DNA and wheat germ agglutinin (WGA), to label carbohydrates. The specimen was then imaged using a spinning disk confocal microscope (Figure 4A,B,D). Tissues were treated following the above protocol and fully expanded in water (Figure 4C,E). Similarly, Figure 5 shows example images of H&E stained normal breast tissue (Figure 5A) that was treated with xylene (section 2.1.2) to remove the cover glass and then treated as an FFPE sample (section 2.1.1). During homogenization, the H&E stain is eliminated from the tissue. Post-expansion images of the DAPI stained sample obtained on a spinning disk confocal microscope (Figure 5B) compared with pre-expansion images indicate an expansion factor of 5.1, giving an effective resolution of ~43 nm when imaged with an NA 1.15 lens.

Example data for unfixed frozen kidney slices processed using the ExPath protocol can be seen in Figure 6. The tissue was first fixed in cold acetone (section 2.1.3) and stained with ACTN4, vimentin, DAPI, and WGA. Comparison of pre-expansion (not shown) and post-expansion images indicate an expansion factor of 4.5. Comparison data from the acetone-fixed frozen kidney samples to that of the FFPE samples (Figure 4C,E) shows that there is a decrease in quality of the ACTN4 staining in the expanded FFPE sample, which may be due to a degradation of the antigenicity due to the fixation method16.

Figure 1
Figure 1: Schematic of the expansion pathology (ExPath) workflow. Pre-processing of clinically archived tissue slides is first performed based on the storage format. Samples are then stained using conventional immunostaining protocols and pre-expansion images are obtained. Samples are then treated with acryloyl-X SE (AcX) to anchor proteins to the hydrogel. In situ polymerization is preformed prior to mechanical homogenization using proteinase K (ProK). Samples can then be expanded in ddH2O prior to imaging. Please click here to view a larger version of this figure.

Figure 2
Figure 2: Gelation chamber for pathology samples. (A) Two spacers, such as two pieces of #1.5 cover glass cut with a diamond knife, are placed on either side of the tissue after incubating the sample in gelling solution at 4 °C. The spacers should be thicker than the tissue slices, to prevent compression of the sample. (B) A lid, such as a piece of #1.5 cover glass, is used to cover the sample prior to incubation at 37 °C. Please click here to view a larger version of this figure.

Figure 3
Figure 3: Example of sample expansion. A 5 µm thick kidney sample post homogenization, (A) pre- and (B) post-expansion in ddH2O is shown. Grid squares are 5 mm x 5 mm. Please click here to view a larger version of this figure.

Figure 4
Figure 4: Representative results from 5 µm thick FFPE kidney samples. (A) Pre-expanded image. (B) Magnified pre-expansion image of the outlined region of interest in panel A and (C) the corresponding post-expansion image of the same region of interest after the sample was fully expanded in water. (D) Magnified image of the outlined region of interest in panel B and (E) the corresponding post-expansion image of the same region of interest after the sample was fully expanded in water. Cracking, distortions, and loss of labeled targets can be the result of inadequate anchoring and/or homogenization (F,G). All images were obtained using a spinning disk confocal microscope with a 20x (NA 0.95; water immersion) objective (A-E,G) or 10x (NA 0.5) objective (F). Blue, DAPI; green, vimentin; red, alpha-actinin 4 (ACTN4); magenta, WGA. Scale bars = 100 µm (A,F,G, yellow scale bars indicate post-expansion images); 50 µm (B), 50 µm (C, physical size post expansion 225 µm; expansion factor 4.5); 25 µm (D); 25 µm (E, physical size post expansion 112.5 µm; expansion factor 4.5). Please click here to view a larger version of this figure.

Figure 5
Figure 5: Representative results from H&E stained normal breast tissue. (A) Brightfield image of pre-expanded H&E stained tissue taken with a 40x (0.95 NA) objective. (B) Post-expansion DAPI image of the same region of interest after the sample was fully expanded in water. The image was obtained on a spinning disk confocal microscope using a 40x (NA 1.15; water immersion) objective. Scale bars = 10 µm (A, the yellow scale bar indicates post-expansion images) and 2 µm (B, physical size post expansion 50.1 µm; expansion factor 5.1). Please click here to view a larger version of this figure.

Figure 6
Figure 6: Representative results of fresh frozen kidney samples after expansion, obtained on a spinning disk confocal microscope with a 40x (NA 1.15; water immersion) objective. Blue = vimentin; green = alpha-actinin 4 (ACTN4); red = collagen IV; grey = DAPI. Scale bar = 10 µm (physical size post expansion 45 µm; expansion factor 4.5). Please click here to view a larger version of this figure.

Component Stock concentration Stock volume (mL) Final concentration Final amount per 10 mL
Sodium acrylate 0.380 g/mL 2.25 0.086 g/mL 0.86 g
Acrylamide 0.500 g/mL 0.50 0.025 g/mL 0.25 g
N,N′-Methylenebisacrylamide 0.020 g/mL 0.50 0.001 g/mL 0.10 g
Sodium chloride 0.292 g/mL 4.00 0.117 g/mL 1.17 g
PBS 10x 1.00 1x 1x
Water 1.15
Total Volume 9.40

Table 1: Components of monomer solution. All concentrations are given in terms of g/mL (w/v) except PBS.

Subscription Required. Please recommend JoVE to your librarian.


or Start trial to access full content. Learn more about your institution’s access to JoVE content here

Here, we present the ExPath protocol16, a variant of proExM5 that can be applied to the most common types of clinical biopsy samples used in pathology, including FFPE, H&E stained, and fresh-frozen specimens on glass slides. Format conversion, antigen retrieval, and immunostaining of the specimens follow commonly used protocols that are not specific to ExPath. Unlike the original proExM protocol9, ExPath relies on a higher concentration of EDTA in the digestion buffer, which improves the expansion of formalin-fixed tissues, as demonstrated in the original ExPath study16. The protocol has been validated in 5−10 µm thick clinical specimens16, but could also be applied to thicker tissue samples with some modification. The most critical steps in this protocol are: 1) the timing of the gelation steps; 2) setup of the gelation chamber; 3) parameters for sample homogenization; and 4) handling of the gel.

The most critical parameter for this protocol is the timing of the gelation steps. If the gelling solution prematurely polymerizes, the sample will not be sufficiently anchored to the gel matrix. Inadequate anchoring and premature gelation can cause distortions, limit expansion, and result in the loss of target molecules (Figure 4F,G). The initiation of gelation is temperature dependent, therefore it is important to keep the mixed gelling solution at 4 °C before placing it on the target specimen. The initiator, APS, should be freshly prepared and added immediately before applying the gelling solution. APS is not stable at RT and can lose efficacy after undergoing freeze-thaw cycles. Insufficient anchoring can also be the result of reduced reactivity of the anchoring compound, AcX, which can lose activity after long term storage or after contact with water. AcX has been found to retain activity after 6 months of storage in a desiccated environment at -20 °C. If premature gelation is not the suspected cause of distortion, a new stock solution of AcX can be prepared.

During the setup of the gelation chamber, air bubbles can become trapped under the cover glass lid. If these bubbles are on top of or directly touching the sample, they can cause distortions. They can be moved away from the specimen by adding more gelling solution through the side of the chamber. To help prevent air bubbles, a small drop of gelling solution can be deposited on the lid before placing it over the tissue.

Sample digestion is dependent on time, temperature, as well as tissue properties, such as thickness and tissue type. Inadequate digestion can also cause distortions and result in an expansion factor that is smaller than expected. If incomplete digestion is suspected, the digestion time and/or ProK concentration can be increased, particularly in the case of thicker tissues. ProK can also lose activity over time. To preserve its activity, ProK should be stored at -20 °C and can be aliquoted into smaller volumes to avoid free-thaw cycles.

Care should be taken when handling homogenized samples, particularly when fully expanded. If the specimen is hard to locate when submerged in liquid, illuminating the container from different angles can scatter incident light to allow visualization of the gel. Fully expanded gels are fragile and can break during handling. Use of soft brushes and plastic spatulas is recommended to transfer the expanded gels.

The ExPath protocol provides a cost-effective alternative to current super-resolution imaging and electron microscopy techniques to interrogate nanoscale structures in clinical biopsy specimens. Although ProK provides even expansion of the sample after homogenization, the loss of proteins prevents interrogation of other targets of interest post-expansion. However, the protocol can be easily performed in any regular wet lab. Most importantly, imaging of nanoscale features can be carried out on conventional wide-field or confocal microscopes that are commonly found in biology laboratories and imaging core facilities.

Subscription Required. Please recommend JoVE to your librarian.


YZ and OB are two of the inventors who have filed for and obtained patent protection on a subset of the technologies described here (US patents US20190064037A1, WO2018157074A1, and WO2018157048A1).


This work was supported by the Faculty Start-up fund from the Carnegie Mellon University (YZ) and NIH Director’s New Innovator Award (DP2 OD025926-01 to YZ).


Name Company Catalog Number Comments
4-hydroxy-TEMPO (4HT) Sigma Aldrich 176141 Inhibitor
6-well glass-bottom plate (#1.5 coverglass) Cellvis P06-1.5H-N
Acetone Fischer Scientifc A18-500
Acrylamide Sigma Aldrich A8887
Acryloyl-X, SE (AcX) Invitrogen A20770
Agarose Fischer Scientifc BP160-100
Ammonium persulfate (APS) Sigma Aldrich A3678 Initiatior
Anti-ACTN4 antibody produced in rabbit Sigma Aldrich HPA001873
Anti-Collagen IV antibody produced in mouse Santa Cruz Biotech sc-59814
Anti-Vimentin antibody produced in chicken Abcam ab24525
Aqua Hold II hydrophobic pen Scientific Device 980402
Breast Common Disease Tissue Array Abcam ab178113
DAPI (1 mg/mL) Thermo Scientific 62248 Nuclear stain
Diamond knife No. 88 CM General Tools 31116
Ethanol Pharmco 111000200
acid (EDTA) 0.5 M
VWR BDH7830-1
FFPE Kidney Sample USBiomax HuFPT072
Goat Anti-Chicken IgY (H+L), Highly Cross-Adsorbed CF488A Biotium 20020
Goat Anti-Chicken IgY (H+L), Highly Cross-Adsorbed CF633 Biotium 20121
Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Alexa Fluor 546 Invitrogen A11010
MAXbind Staining Medium Active Motif 15253 Can be substituted with non-commercial staning buffer of choice.
MAXblock Blocking Medium Active Motif 15252 Can be substituted with non-commercial blocking buffer of choice.
MAXwash Washing Medium Active Motif 15254 Can be substituted with non-commercial washing buffer of choice.
Micro cover Glass #1 (24 mm x 60 mm) VWR 48393 106
Micro cover Glass #1.5 (24 mm x 60 mm) VWR 48393 251
Tetramethylethylenediamine (TEMED)
Sigma Aldrich T9281 Accelerator
N,N′-Methylenebisacrylamide Sigma Aldrich M7279
Normal goat serum Jackson Immunoresearch 005-000-121 For preparing blocking buffer. Dependent on animal host of secondary antibodies.
Nunclon 4-Well x 5 mL MultiDish Cell Culture Dish Thermo Fisher 167063 Multi-well plastic culture dish
Nunclon 6-Well Cell Culture Dish Thermo Fisher 140675
Nunc 15 mL Conical Thermo Fisher 339651
Nunc 50 mL Conical Thermo Fisher 339653
Orbital Shaker
Paint brush
pH Meter
Phosphate Buffered Saline (PBS), 10x Solution Fischer Scientifc BP399-1
Plastic Petri Dish (100 mm) Fischer Scientifc FB0875713
Proteinase K (Molecular Biology Grade) Thermo Scientific EO0491
Razor blade Fischer Scientifc 12640
Safelock Microcentrifuge Tubes 1.5 mL Thermo Fisher 3457
Safelock Microcentrifuge Tubes 2.0 mL Thermo Fisher 3459
Sodium acrylate Sigma Aldrich 408220
Sodium chloride Sigma Aldrich S6191
Sodium citrate tribasic dihydrate Sigma Aldrich C8532-1KG
Tris Base Fischer Scientifc BP152-1
Triton X-100 Sigma Aldrich T8787
Wheat germ agglutinin labeled with CF640R Biotium 29026
Xylenes Sigma Aldrich 214736



  1. Hell, S. W. Far-Field Optical Nanoscopy. Science. 316, (5828), 1153-1158 (2007).
  2. Combs, C. A., Shroff, H. Fluorescence microscopy: A concise guide to current imaging methods. Current Protocols in Neuroscience. 79, (1), 2.1.1-2.1.25 (2017).
  3. Schermelleh, L., Heintzmann, R., Leonhardt, H. A guide to super-resolution fluorescence microscopy. Journal of Cell Biology. 190, (2), 165-175 (2010).
  4. Chen, F., Tillberg, P. W., Boyden, E. S. Expansion microscopy. Science. 347, (6221), 543-548 (2015).
  5. Tillberg, P. W., et al. Protein-retention expansion microscopy of cells and tissues labeled using standard fluorescent proteins and antibodies. Nature Biotechnology. 34, 987-992 (2016).
  6. Chozinski, T. J., et al. Expansion microscopy with conventional antibodies and fluorescent proteins. Nature Methods. 13, (6), 485-488 (2016).
  7. Ku, T., et al. Multiplexed and scalable super-resolution imaging of three-dimensional protein localization in size-adjustable tissues. Nature Biotechnology. 34, (9), 973-981 (2016).
  8. Truckenbrodt, S., Maidorn, M., Crzan, D., Wildhagen, H., Kabatas, S., Rizzoli, S. O. X10 expansion microscopy enables 25-nm resolution on conventional microscopes. EMBO Reports. 19, (9), e45836 (2018).
  9. Asano, S. M., et al. Expansion Microscopy: Protocols for Imaging Proteins and RNA in Cells and Tissues. Current Protocols in Cell Biology. 80, (1), 1-41 (2018).
  10. Chen, F., et al. Nanoscale imaging of RNA with expansion microscopy. Nature Methods. 13, (8), 679-684 (2016).
  11. Tsanov, N., et al. SmiFISH and FISH-quant - A flexible single RNA detection approach with super-resolution capability. Nucleic Acids Research. 44, (22), e165 (2016).
  12. Wang, G., Moffitt, J. R., Zhuang, X. Multiplexed imaging of high-density libraries of RNAs with MERFISH and expansion microscopy. Scientific Reports. 8, (1), 1-13 (2018).
  13. Chang, J. B., et al. Iterative expansion microscopy. Nature Methods. 14, (6), 593-599 (2017).
  14. Cipriano, B. H., et al. Superabsorbent hydrogels that are robust and highly stretchable. Macromolecules. 47, (13), 4445-4452 (2014).
  15. Truckenbrodt, S., Sommer, C., Rizzoli, S. O., Danzl, J. G. A practical guide to optimization in X10 expansion microscopy. Nature Protocols. 14, (3), 832-863 (2019).
  16. Zhao, Y., et al. Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy. Nature Biotechnology. 35, (8), 757-764 (2017).
Nanoscopic Imaging of Human Tissue Sections via Physical and Isotropic Expansion
Play Video

Cite this Article

Klimas, A., Bucur, O., Njeri, B., Zhao, Y. Nanoscopic Imaging of Human Tissue Sections via Physical and Isotropic Expansion. J. Vis. Exp. (151), e60195, doi:10.3791/60195 (2019).More

Klimas, A., Bucur, O., Njeri, B., Zhao, Y. Nanoscopic Imaging of Human Tissue Sections via Physical and Isotropic Expansion. J. Vis. Exp. (151), e60195, doi:10.3791/60195 (2019).

Copy Citation Download Citation Reprints and Permissions
View Video

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
simple hit counter